Literature DB >> 26151077

Teleoncology for gynecologic cancers.

David I Shalowitz1, Allison G Smith2, Maria C Bell3, Randall K Gibb4.   

Abstract

Teleoncology describes cancer care provided remotely to improve access to care in rural or underserved areas. In the United States, 14.8 million women live more than 50 miles away from the closest gynecologic oncologist; 4.3 million women live more than 100 miles distant. Teleoncology may therefore partially relieve the geographic barriers to high-quality gynecologic cancer care these women experience. Little has been published on the feasibility of remote provision of high-quality care for gynecologic cancers, perhaps owing to the particular difficulties inherent in remote management of patients who may require both medical and surgical intervention. In this article, we review the data supporting the use of telemedicine in the treatment of cancer patients with a specific focus on applicability to management of gynecologic malignancies. We further add our group's experience with the treatment of rural, underserved gynecologic cancer patients. We believe that development of teleoncologic systems is critical to ensure that all women have access to high-quality gynecologic cancer care, regardless of where they reside.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Access disparities; Cancer care delivery research; Health services research; Telemedicine; Teleoncology

Mesh:

Year:  2015        PMID: 26151077     DOI: 10.1016/j.ygyno.2015.06.042

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Telemedicine in Neurological Disorders: Opportunities and Challenges.

Authors:  Martina Chirra; Luca Marsili; Linsdey Wattley; Leonard L Sokol; Elizabeth Keeling; Simona Maule; Gabriele Sobrero; Carlo Alberto Artusi; Alberto Romagnolo; Maurizio Zibetti; Leonardo Lopiano; Alberto J Espay; Ahmed Z Obeidat; Aristide Merola
Journal:  Telemed J E Health       Date:  2018-08-23       Impact factor: 3.536

2.  Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Authors:  Sherri L Stewart; Rhea Harewood; Melissa Matz; Sun Hee Rim; Susan A Sabatino; Kevin C Ward; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

3.  Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.

Authors:  Sherri L Stewart; Julie S Townsend; Mary C Puckett; Sun Hee Rim
Journal:  J Womens Health (Larchmt)       Date:  2016-03       Impact factor: 2.681

4.  Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum.

Authors:  Lindsey A McAlarnen; Shirng-Wern Tsaih; Rana Aliani; Natasha M Simske; Elizabeth E Hopp
Journal:  Gynecol Oncol       Date:  2021-05-11       Impact factor: 5.304

5.  Gynecologic oncology patients are ready for telemedicine in routine care: Results from a pre-COVID survey.

Authors:  J Dholakia; J Kim; M I Liang; R C Arend; K S Bevis; J M Straughn; C A Leath; W K Huh; H J Smith
Journal:  Gynecol Oncol Rep       Date:  2021-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.